title: Analysis of giant cell tumor of bone with pulmonary metastases.
abstract: The authors reviewed 6 cases of giant cell tumor of bone with pulmonary metastases, analyzed the growth rate of the metastases, and performed flow cytometry on paraffin blocks from primary and metastatic lesions. Surgery on the pulmonary metastases was done in 3 cases. Chemotherapy was administered in all 6 cases. If the doubling time of the pulmonary metastases was more than 80 days, the case was considered to be slow growing or in regression. However, if the doubling time was approximately 30 days, the prognosis was poor. The cases were divided into 3 types according to the prognosis. After chemotherapy (cyclophosphamide), the pulmonary metastases decreased in size in 2 cases. In 2 other cases, the metastases were slow growing, and the remaining 2 patients died early. Flow cytometric analysis was performed on primary and metastatic lesions, which showed a diploid pattern in most cases, but a tetraploid pattern in 1 recurrent case. Pulmonary metastatic lesions displayed a diploid pattern in 4 cases from which materials were taken either at surgery or autopsy.
authors.affiliation: Department of Orthopaedic Surgery, Nihon University School of Medicine, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Osaka
authors.forename: M
authors.initials: M
authors.lastname: Toriyama
authors.forename: K
authors.initials: K
authors.lastname: Taira
authors.forename: S
authors.initials: S
authors.lastname: Sano
authors.forename: K
authors.initials: K
authors.lastname: Saotome
mesh_terms: D000293:Adolescent; D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000473:pathology*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004171:Diploidy; D005260:Female; D005434:Flow Cytometry; D005870:Giant Cell Tumors / Q000235:genetics / Q000556:secondary* / Q000628:therapy; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000556:secondary* / Q000628:therapy; D008297:Male; D011013:Pneumonectomy / Q000379:methods; D011379:Prognosis
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003520:Cyclophosphamide